Ligand Pharmaceuticals Incorporated Development Agreements
4 Contracts & Agreements
- Amendment No. 2 to Development Funding and Royalties Agreement, dated as of November 29, 2023, by and between the Company and Palvella Therapeutics, Inc (Filed With SEC on February 29, 2024)
- Amendment No. 1 to Development Funding and Royalties Agreement, dated as of May 22, 2020, by and between the Company and Palvella Therapeutics, Inc (Filed With SEC on February 29, 2024)
- Development Funding and Royalties Agreement, dated December 13, 2018, by and between Ligand Pharmaceuticals Incorporated and Palvella Therapeutics, Inc (Filed With SEC on February 28, 2019)
- AMENDMENT NO. 2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on November 9, 2009)